Quote:
Originally Posted by Neil Cuadra
shadowii,
I suggest that you attend this MDS Foundation webinar:
Clinical Implications of Genetic Mutations in Myelodysplastic Syndromes
April 17, 2021, 12:00pm ET
Dr. Rami Komrokji of the Moffitt Cancer Center will provide an overview of recent advances in the genetic understanding of MDS, with a particular focus on the emerging role for mutational data in clinical management as a potential tool to assist in diagnosis, risk stratification, and therapeutic decision-making. Registration link |
Thanks neil, I've seen reasons to be hopeful and reasons not to be and I knew that going in it was only 50/50 whether it would work (with the other percent relapse or death from complications to surgery)
but for most of 2020 it looked like we were in the clear (which isnt really true his counts never did return to normal and he got pneumonia in July but most of the months felt good)
and with worsening statistics at this point i'm just not sure if being hopeful is reasonable at this point
I cant bear the thought of loosing him